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Introduction 
Improvement of the dissolution rates of water-insoluble 
drugs is one of the most challenging issues of drug 
development, because the enhanced dissolution rates can 
enhance drug oral bioavailability. 
1
 The solid dispersion 
technique for water-insoluble drugs developed by Chiou 
and Reigelman
2
 supplies an effective way to increase the 
dissolution rates of drugs. 
3,4
 Details of different types of 
solid dispersion systems and the mechanisms of drug 
release from these systems have been reviewed in 
details.
2
 Solid dispersion can be prepared by formulating 
supersaturated systems of the drug employing various 
types of carriers, ranging widely from water-soluble to 
amphiphilic and lipid-soluble ones.
4–7
 Drugs molecularly 
dispersed in proper carriers may reach the maximum 
levels of particle size reduction, therefore the surface 
area increase, which results in enhanced dissolution 
rates.
8
 
Numerous attempts 
9-16
 have been made to improve the 
dissolution rate of prednisolone, a very slightly water 
soluble glucocorticoid to obtain more rapid and complete 
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Introduction: Prednisolone is a class II substance according to the Biopharmaceutics 
Classification System. It is a poorly water soluble agent. The aim of the present study was 
to improve dissolution rate of a poorly water-soluble drug, prednisolone, by a solid 
dispersion technique. Methods: Solid dispersion of prednisolone was prepared with PEG 
6000 or different carbohydrates such as lactose and dextrin with various ratios of the drug 
to carrier i.e., 1:10, 1:20 and 1:40. Solid dispersions were prepared by coevaporation 
method. The evaluation of the properties of the dispersions was performed using 
dissolution studies, Fourier-transform infrared spectroscopy and x-ray powder 
diffractometery. Results: The results indicated that lactose is suitable carriers to enhance 
the in vitro dissolution rate of prednisolone. The data from the x-ray diffraction showed 
that the drug was still detectable in its solid state in all solid dispersions except solid 
dispersions prepared by dextrin as carrier. The results from infrared spectroscopy showed 
no well-defined drug–carrier interactions for coevaporates. Conclusion: Solid dispersion 
of a poorly water-soluble drug, prednisolone may alleviate the problems of delayed and 
inconsistent rate of dissolution of the drug. 
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absorption. One of the limitations of common solvent 
method is the need for a solvent that dissolves 
hydrophilic carrier and hydrophobic drug at the same 
time which may not be applicable for some carriers such 
as carbohydrates. In our previous investigations we have 
demonstrated that co-evaporates with hydrophilic 
carriers could be prepared by using two different but 
mutually soluble solvents.
17,18
 Therefore the need for a 
common solvent of drug and carrier is not considered as 
an absolute requisite for preparation of co-evaporates. 
This broadens the application of the co-evaporation 
technique for more extensive range of drugs and carriers.  
In the present study, efforts were made to improve the 
dissolution behavior and consequently absorption, of 
prednisolone by applying the solid dispersion technique 
using lactose, dextrin, and PEG 6000 as hydrophilic 
carriers. 
Materials and methods 
Materials 
For preparation of solid dispersions the following 
materials were used: lactose monohydrate (DMV, 
Netherland); mannitol, dextrin, PEG 2000, PEG 4000, 
PEG 6000 (Merck, Germany); prednisolone (Abureihan, 
Iran); Chemicals used for buffer preparation were 
reagent grade. All other materials used were of analytical 
or high performance liquid chromatography (HPLC) 
grade and were purchased from Merck (Germany). 
Preparation of solid dispersions, physical mixtures and 
treated physical mixtures 
Physical mixtures were prepared by mixing prednisolone 
with the hydrophilic carriers for 5 min in 100 mL bottles, 
until a homogenous mixture was obtained. The resulting 
mixture was sieved and the 105–250 micron particle size 
fraction was obtained using 60-140 mesh screens. The 
powders were stored in a screw-cap vial at room 
temperature. 
Treated physical mixtures were prepared by mixing 
treated drug and treated carriers in 100-mL bottles. 
Treated drug was prepared by mixing alcoholic solution 
of prednisolone with distilled water until a homogenous 
mixture was obtained. Treated carrier was prepared by 
dissolving it in water and adding alcohol 96% until a 
homogenous mixture was obtained.  
The objective of preparation of treated physical mixtures 
is to investigate if evaporation of the drug and carrier 
separately may affect release of the drug from solid 
dispersions.  
Coevaporates were prepared in the following 
prednisolone-carrier ratios: 1:10, 1:20, and 1:40 (w/w). 
Coevaporates were prepared by dissolving the 
components separately in a minimum volume of ethanol 
or distilled water, respectively. The alcoholic solution of 
prednisolone was then poured into the aqueous solution 
of the carrier under continuous stirring. The mixture was 
then heated in a water bath (70°C) under vacuum and 
vigorous stirring.  
Initially, a transparent to a translucent viscous mass was 
observed and finally a pale yellow coevaporate was 
formed. The moist mass was transferred to a vacuum 
desicator and kept at 50oC overnight. The solid mass 
was ground and the particle size fraction of 105–250 
micron was separated using 60-140 mesh screens and 
kept in a screw-capped glass vial until use. 
 
Dissolution studies 
Hand–filled, hard gelatin capsules of the formulations, 
containing 5 mg of the drug, were used for the 
dissolution studies. The test was conducted using USP 
30 Apparatus I at 50 rpm. The dissolution medium 
consisted of 900 ml distilled water which was 
maintained at 37 (±0.5) °C. The duration of the test was 
30 minutes. A 5-ml aliquots were withdrawn at 
appropriate time intervals, and replaced with a 5 ml of 
distilled water and assayed by UV spectrophotometry at 
246.8 nm. Cumulative percentages of the drug dissolved 
from the preparations were calculated. Three replicates 
of each dissolution test were carried out. 
Mean percent dissolution (MPD) and dissolution 
efficiency (DE)
19
, were used to compare dissolution 
profiles of binary systems Eq. (1): 
n
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Wherei is the sample number, n is the number of 
dissolution sample times and PD is the percent drug 
dissolved at time intervals Eq. (2): 
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      (2) 
Where Y is percent drug released as a function of time, T 
is the total time of drug release and Y100 is 100 percent 
drug released. 
Powder X-ray diffraction 
The powder X-ray diffraction (PXRD) pattern of all 
ingredients and all binary systems were recorded using 
an automated siemens X-ray diffractometer (Siemens 
D5000, Munich, Germany). Cross sections of the 
ingredients and all binary systems were taken and held in 
place on a quartz plate to Cu Kα radiation of wave length 
1.5406 A°. The samples were analyzed at room 
temperature over a range of 5-70° 2 with sampling 
intervals of 0.02° 2 and scanning rate of 6°/min. 
 50    | Advanced Pharmaceutical Bulletin, 2011, 1(1), 48-53 Copyright © 2011 by Tabriz University of Medical Sciences 
Prednisolone solid dispersion 
Fourier-transform infrared spectroscopy 
Fourier-transform infrared Spectroscopy (FT-IR) were 
obtained on a Bomem 2000 FT-IR system (Bomem 
Quebec, Canada) using the KBr disk method. Samples 
were mixed with KBr powder and compressed to 10-mm 
discs by hydraulic press at pressure of 10 tons for 30 
seconds. The scanning range was 450-4000 cm
-1
 and 
resolution was 2 cm
-1
. 
Results and discussion 
Dissolution studies 
The release of prednisolne from solid dispersions, 
physical mixtures and treated physical mixtures was 
determined in distilled water. DE and MPD values are 
represented in Table 1. 
 
Table 1. DE and MPD of prednisolone-carrier binary systems (standard deviations were all less than 10%). 
Sample 
Pure 
drug 
Solid dispersion Treated Physical 
mixture 
Physical mixture 
Drug Carrier Ratio - 1:10 1:20 1:40 1:40 1:10 1:20 1:40 
Without carrier 
DE 20.65 - - - - - - - 
MPD 18.32 - - - - - - - 
Lactose DE - 80.98 83.18 80.71 71.24 65.39 73.73 70.24 
MPD - 73.05 75.12 72.95 63.77 57.80 66.60 62.45 
Dextrin DE - 50.62 62.49 68.82 65.28 31.42 38.11 39.51 
MPD - 45.10 56.00 61.31 58.37 27.47 33.68 34.41 
PEG 6000 DE - 60.93 60.78 53.74 55.18 42.36 51.61 43.25 
MPD - 53.95 52.90 46.05 48.42 35.76 44.14 37.17 
 
 
 
It is evident that the dissolution rate of the solid 
dispersions of prednisolone prepared with lactose, 
dextrin and PEG 6000, are higher than that of pure drug 
and physical mixtures of ingredients. Moreover the 
dissolution rate of treated physical mixtures was higher 
compared to related physical mixtures.  
Possible explanations of the increased dissolution rate of 
solid dispersions have been proposed by Craig and Ford 
20,21
 , which include: reduction of drug crystallite size, a 
solubilization effect of the carrier, absence of 
aggregation of drug crystallites, improved wettability 
and dispersibility of the drug, dissolution of the drug in 
the hydrophilic carrier, conversion of the drug to the 
amorphous state and finally the combination of the 
above mentioned mechanisms. 
Dry mixing of prednisolone with carrier brings the drug 
in close contact with the hydrophilic carrier. The 
increased dissolution rate observed in these cases can be 
contributed to several factors such as a solubilization 
effect of the carrier, improved wettability of the drug and 
inhibition of particle aggregation.  
Dissolution profiles of solid dispersions with lactose 
showed an increase in the dissolution rate of 
prednisolone with respect to the drug by itself which 
could be due to high hyrophilicity of lactose (Figure 1). 
Also, increasing the weight fraction of prednisolone in 
the solid dispersions did not affect noticeably the 
dissolution rate of the dispersions prepared with 
lactose(Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Dissolution profiles of physical mixtures (PM), treated 
physical mixtures (TPM) and solid dispersions (SD) of 
prednisolone with lactose and Dextrin. 
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Figure 2. FT-IR spectra of pure prednisolone, lactose, 1:40 physical mixture (PM) of prednisolone with lactose, and 1:40 solid 
dispersion (SD) of prednisolone with lactose 
 
 
This is not unexpected, as it has been previously shown 
that an increase in the weight fraction of the drug does 
not necessarily decrease the dissolution rate. 
17, 22
Hence 
utilizing lactose in a ratio of 1:10 should be enough for 
reaching higher dissolution rate. 
As it can be seen from Figure 1, the solid dispersion of 
the drug with dextrin showed enhanced dissolution 
rate.
17, 18
 
Compared to the drug alone, an improvement in the 
dissolution rate was achieved for the formulations 
containing PEG 6000. Dissolution rate was decreased 
increasing the ratio of PEG 6000. This phenomenon may 
be attributed to formation of viscous boundary layer at 
the surface of the polymer at higher carrier ratios. 
However, the release of prednisolone from treated 
physical mixtures in the ratio of (1:40) was slightly 
faster than the release from coevaporates. This could be 
due to the fact that dissolution mechanism of solid 
dispersion with PEG 6000 might be predominantly 
diffusion-controlled, and presumably the high viscosity 
of this carrier in stagnate layer is the main factor to 
control the dissolution rate. 
 
Powder X-Ray Diffraction (PXRD) 
The extent of crystallinity affects dissolution of drugs. 
An amorphous or metastable form will dissolve 
promptly because of its higher internal energy and 
greater molecular motion, which increase 
thermodynamic properties compared to crystalline 
materials.
23,24 
Crystallinity was determined by comparing 
some representative peak heights in diffraction patterns 
of the solid dispersions with those of physical mixtures. 
Our findings revealed that prednisolone was in its 
crystalline forms in the physical mixtures and solid 
dispersions prepared with lactose without any change 
compared to the corresponding treated physical mixtures 
and physical mixtures of the drug. On the contrary solid 
dispersions prepared with dextrin were characterized by 
the complete absence of any diffraction peaks, 
suggesting a complete amorphization in the amorphous 
carrier. In the case of solid dispersions prepared with 
PEG 6000, prednisolone was still detectable in 
crystalline form. Therefore no complete amorphization 
occurred. 
 
Fourier-transform infrared spectroscopy 
Fourier-transform infrared (FT-IR) spectroscopy was 
used to further characterize possible interactions between 
the drug and carrier in the solid state. From the structures 
of the prednisolone, lactose, dextrin and PEG 6000, it 
can be assumed that possible interaction could occur 
between thehydroxyl or carbonyl group of prednisolone 
and the hydroxyl group of these carriers. Any sign of 
interaction would be reflected by a change in the 
position of C=O vibration and disappearance of O-H 
stretching depending on the extent of interaction. 
The results from FT-IR spectroscopy showed that 
incorporation of prednisolone into PEG 6000, lactose, 
did not modify their peak positions and trends. These 
results further indicate the absence of well-defined 
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interaction between prednisolone and PEG 6000, lactose 
as already confirmed from the X-ray diffraction study. 
The spectrum of prednisolone showed characteristic 
bands of the OH group which were found at 3200-3500 
cm
-1
 (OH involved in intermolecular association). Two 
carbonyl stretching peaks appears as a very strong band 
at 1708 cm
-1
 and 1654 cm
-1
. The spectrum of dextrin 
showed, amongst others, important bands at 2953 cm
-1
 
(C–H stretching) and 1109 cm-1 (C–O stretching). A 
very broad band was also visible at 3446 cm
-1
, which 
was attributed to the presence of water. Important 
vibrations detected in the spectrum of PEG 6000 are the 
C–H stretching at 2890 cm-1 and the C–O stretching at 
1110 cm
-1
 and OH stretching at 3350 cm
-1
. Comparing 
the spectra of physical mixtures and solid dispersions of 
prednisolone with lactose, PEG 6000, and dextrin no 
difference was shown in the position of the absorption 
bands. The spectra can be simply regarded as the 
superposition of those of prednisolone and carrier. 
Although it could be expected to have hydrogen bonding 
between the hydrogen atom of the OH of the drug and 
one of the ione pairs of the oxygen atom in carrier, this 
could not be demonstrated. 
 
Conclusion 
An increased dissolution rate of prednisolone solid 
dispersions was observed with increasing the ratio of 
dextrin to the drug. Controversially, the dissolution rate 
of the drug was not varied upon increasing the ratio of 
the carrier to the drug when the drug was dispersed in 
lactose. However decreased dissolution rate of the solid 
dispersions was achieved by increasing the ratio of PEG 
6000.  
In conclusion improving the dissolution rate of 
prednisolone solid dispersions using polysaccharides like 
lactose is more appropriate than using dextrin and PEG 
6000. 
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